|
CD300LG expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.34120000053295E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.32070000053086E-07 |
| Normal-vs-Stage2 |
7.519500E-03 |
| Normal-vs-Stage3 |
8.16849998752645E-09 |
| Normal-vs-Stage4 |
5.375500E-02 |
| Stage1-vs-Stage2 |
1.159640E-01 |
| Stage1-vs-Stage3 |
5.815700E-02 |
| Stage1-vs-Stage4 |
4.890400E-01 |
| Stage2-vs-Stage3 |
1.737690E-02 |
| Stage2-vs-Stage4 |
8.646800E-01 |
| Stage3-vs-Stage4 |
2.483600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62049999974379E-07 |
| Normal-vs-AfricanAmerican |
4.479200E-01 |
| Normal-vs-Asian |
5.8896000298958E-09 |
| Caucasian-vs-AfricanAmerican |
4.966600E-01 |
| Caucasian-vs-Asian |
5.101700E-02 |
| AfricanAmerican-vs-Asian |
3.652400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.5783000000067E-05 |
| Normal-vs-Female |
4.32670000050095E-07 |
| Male-vs-Female |
9.353400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.22519999701254E-08 |
| Normal-vs-Age(41-60Yrs) |
2.012099997728E-08 |
| Normal-vs-Age(61-80Yrs) |
1.001860E-02 |
| Normal-vs-Age(81-100Yrs) |
3.96859999995947E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.446300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.081500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.302200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.699400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.385600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.346200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.779890E-04 |
| Classical-VS-Follicular |
1.600530E-03 |
| Classical-VS-Other |
4.02060000004312E-06 |
| Classical-VS-Normal |
1.28670000210107E-08 |
| Tall-VS-Follicular |
5.24910000021528E-07 |
| Tall-VS-Other |
2.030000E-01 |
| Tall-VS-Normal |
1.50349954708417E-10 |
| Follicular-VS-Other |
7.33139999820054E-08 |
| Follicular-VS-Normal |
1.628480E-02 |
| Other-VS-Normal |
3.46559447805816E-11 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.80810000036413E-07 |
| Normal-vs-N1 |
1.06060000004682E-07 |
| N0-vs-N1 |
6.897900E-02 |
|
|
